Result of EGM

RNS Number : 0135N

Avacta Group PLC

09 February 2009

 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

London, 9 February 2009

Avacta Group plc ('Avacta')

Offer Update: Result of Shareholder Meeting

The Avacta Board is pleased to announce that, at the Avacta General Meeting held earlier today in relation to

the recommended offer for Curidium Medica plc ('Curidium') by Avacta (the 'Proposed Acquisition'), the Avacta Resolutions necessary to effect the Proposed Acquisition were passed by the requisite majorities.

The number of proxy votes lodged for each resolution before the meeting was as follows:

	Total For*		Total Against		Votes Withheld
Resolution	No. of votes	%age of vote	No. of votes	%age of vote	No. of votes
1. To allot equity securities in connection with the Scheme	297,483,904	98.6	60,000	0.02	0
2. To adopt the EMI Scheme	297,543,904	98.6	0	0	0

*Figures do not include discretionary votes.

Implementation of the Scheme of Arrangement remains conditional upon the approval by Curidium Scheme Shareholders of the resolutions at the Curidium General Meeting and of the Scheme of Arrangement at the Court Meeting, both of which are due to be held on 11 February 2009, and the satisfaction or (where applicable) waiver of the other Conditions set out in the Scheme Document posted to Curidium Shareholders on 16 January 2009.

On the basis that the Curidium resolutions are passed and that the Court sanctions the Scheme of Arrangement and confirms the associated Reduction of Capital at the Court Hearing scheduled to take place on 2 March 2009, it is anticipated that, on 3 March 2009 the Scheme will become effective and that dealings in the New Avacta Shares will commence on 4 March 2009. New Avacta Shares will be credited to CREST accounts on the same date. It is expected that share certificates for New Avacta Shares will be dispatched by no later than 17 March 2009.

Copies of the Avacta Resolutions passed at the Avacta General Meeting will be available for inspection by the public from tomorrow at the offices of Avacta at York Biocentre, York Science Park, Innovation Way, Heslington, York YO10 5NY and also those of Walker Morris situated at: Kings Court, 12 Kings Street, Leeds LS1 2HL during normal business hours on any weekday (public holidays excepted) until 4 March 2009. 

Terms used but not defined in this announcement shall have the same meaning as in the Scheme Document dated 16 January 2009.

Enquiries

Avacta

Dr Alastair Smith, Chief Executive Officer

Tim Sykes, Chief Financial Officer

Tel: [phone]

Curidium

Dr. Barry Porter, Chairman

Rob Smith, Chief Financial Officer

Tel: [phone]

Novum Securities Limited (financial adviser to Avacta)

Henry Turcan 

Tel: [phone]

FinnCap (financial adviser to Curidium)

Charlie Cunningham

Tel: [phone]

Haggie Financial (PR to Avacta)

Nicholas Nelson 

Tel: [phone]

Novum Securities Limited, which is authorised and regulated in the UK by the Financial Services Authority, is acting as financial adviser to Avacta in connection with the Recommended Offer and no-one else and will not be responsible to anyone other than Avacta for providing the protections afforded to clients of Novum Securities nor for providing advice in relation to the Recommended Offer nor any other matter referred to in this announcement. 

FinnCap, which is authorised and regulated in the UK by the Financial Services Authority, is acting as financial adviser and broker to Curidium in connection with the Recommended Offer and no-one else and will not be responsible to anyone other than Curidium for providing the protections afforded to clients of FinnCap nor for providing advice in relation to the Recommended Offer nor any other matter referred to in this announcement. 

 

END

 

 

REGEAAANEDPNEFE